Companies / Israel
J&J Acquires ColdBar
March 2006 | FDI AlertUS drugmaker Johnson & Johnson has acquired Israeli healthcare firm ColdBar for US$140mn. ColdBar manufactures collagen-based implants and has developed two new products to date, Ossix, which is for the dental market, and Evolence, an aesthetic treatment used for facial wrinkles. A number of products are currently being developed by the company for the urological, orthopaedic and other fields. Evolence is expected to be launched on the US some time in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
